Eli Lilly has created tirzepatide (Zepbound), which incorporates the activity of another incretin-like peptide, GIP, into the GLP-1 framework [22]
Multiple test types (HPLC, MS, amino acid analysis) provide more confidence than single-method verification
A personalized program ensures that if you do experience side effects like itchy skin, you have a clinical team available to help you navigate them and adjust your dosage or administration technique as needed
The most important predictors of distress included a personal history of melanoma, having concerns about the impact of melanoma on family, having a high information-seeking disposition (monitoring style), a perceived importance of sun exposure in causing melanoma, and not having children
Typically, a patient will not be on their GLP-1 medication forever